| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | $0.0B | $0.0B | $0.0B |
| Net Income | $0.1B | $0.1B | $0.1B | $-0.1B | $0.0B | $0.1B | $0.0B | $-0.0B |
| EPS (Basic) | $1.19 | $1.36 | $0.89 | $-1.43 | $2.58 | $0.39 | $1.76 | $1.52 |
| EPS (Diluted) | $1.19 | $1.36 | $0.89 | $-1.43 | $2.58 | $0.39 | $1.76 | $1.52 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $19.4B | $16.3B | $15.3B | $14.1B | $5.2B | $3.4B | $4.3B | $4.0B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.0B |
| Total Liabilities | $17.5B | $14.7B | $13.8B | $12.9B | $3.9B | $2.5B | $3.5B | $3.4B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.8B | $1.6B | $1.5B | $1.2B | $1.3B | $0.9B | $0.8B | $0.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.9B | $-0.4B | $-0.2B | $0.0B | $0.1B | $0.1B | $0.1B | $-0.5B |
| Investing Cash Flow | $-4.1B | $-0.7B | $0.2B | $-1.8B | $-2.0B | $0.5B | $-1.7B | — |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $5.1B | $1.1B | $0.1B | $1.8B | $2.0B | $-0.6B | $1.6B | $0.5B |